SIM
INSY

Sonora Investment Management’s Insys Therapeutics, Inc. INSY Stock Holding History

Sonora Investment Management’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-600
Closed -$3.62K – 1234
2018
Q1 		$3.62K Hold
600
– – ﹤0.01% 992
2017
Q4 		$5.77K Hold
600
– – ﹤0.01% 926
2017
Q3 		$5.33K Hold
600
– – ﹤0.01% 851
2017
Q2 		$7.59K Hold
600
– – ﹤0.01% 782
2017
Q1 		$6.31K Hold
600
– – ﹤0.01% 753
2016
Q4 		$5.52K Hold
600
– – ﹤0.01% 689
2016
Q3 		$7.07K Buy
+600
New +$9.12K ﹤0.01% 640

Other funds holding INSY

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Sonora Investment Management's INSY Position: Q2 2018 in Review

Sonora Investment Management sold out of Insys Therapeutics, Inc. (INSY) in Q2 2018, closing a stake of 600 shares — an estimated $3.62K sold.

Sonora Investment Management first reported a position in INSY in Q3 2016 and held it in 7 quarters. The position peaked at $7.59K in Q2 2017. 103 funds tracked by Wall St. Rank hold INSY as of Q2 2018.

  • Sonora Investment Management reported no remaining Insys Therapeutics, Inc. position as of Q2 2018 after selling out during the quarter.
  • Sonora Investment Management sold 600 Insys Therapeutics, Inc. shares in Q2 2018, an estimated $3.62K.
  • Sonora Investment Management first reported a position in Insys Therapeutics, Inc. in Q3 2016 and held it in 7 quarters.
  • Sonora Investment Management's Insys Therapeutics, Inc. position peaked at $7.59K in Q2 2017.
  • 103 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2018.

Based on Sonora Investment Management's 13F filing for Q2 2018, filed 6 Aug 2018.